nodes	percent_of_prediction	percent_of_DWPC	metapath
Prochlorperazine—breast cancer—Medroxyprogesterone Acetate—uterine cancer	0.825	1	CpDpCtD
Prochlorperazine—CYP2D6—Progesterone—uterine cancer	0.0217	0.296	CbGbCtD
Prochlorperazine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0208	0.284	CbGbCtD
Prochlorperazine—CYP3A4—Progesterone—uterine cancer	0.0138	0.188	CbGbCtD
Prochlorperazine—CYP2D6—Doxorubicin—uterine cancer	0.00663	0.0903	CbGbCtD
Prochlorperazine—CYP3A4—Etoposide—uterine cancer	0.00618	0.0842	CbGbCtD
Prochlorperazine—CYP3A4—Doxorubicin—uterine cancer	0.00421	0.0574	CbGbCtD
Prochlorperazine—Hepatocellular injury—Medroxyprogesterone Acetate—uterine cancer	0.000799	0.00787	CcSEcCtD
Prochlorperazine—Venous thromboembolism—Doxorubicin—uterine cancer	0.000796	0.00784	CcSEcCtD
Prochlorperazine—Pigmentation disorder—Epirubicin—uterine cancer	0.000757	0.00746	CcSEcCtD
Prochlorperazine—Nasal congestion—Progesterone—uterine cancer	0.000703	0.00692	CcSEcCtD
Prochlorperazine—Pigmentation disorder—Doxorubicin—uterine cancer	0.000701	0.00691	CcSEcCtD
Prochlorperazine—Increased appetite—Progesterone—uterine cancer	0.000681	0.00671	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Progesterone—uterine cancer	0.000661	0.00652	CcSEcCtD
Prochlorperazine—Haemolytic anaemia—Medroxyprogesterone Acetate—uterine cancer	0.000642	0.00633	CcSEcCtD
Prochlorperazine—Cyanosis—Etoposide—uterine cancer	0.000637	0.00628	CcSEcCtD
Prochlorperazine—Increased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000617	0.00608	CcSEcCtD
Prochlorperazine—Laryngospasm—Etoposide—uterine cancer	0.000604	0.00595	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Medroxyprogesterone Acetate—uterine cancer	0.000599	0.00591	CcSEcCtD
Prochlorperazine—Infection—Carboplatin—uterine cancer	0.000595	0.00586	CcSEcCtD
Prochlorperazine—Hypoglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.000594	0.00586	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Dactinomycin—uterine cancer	0.000585	0.00577	CcSEcCtD
Prochlorperazine—Asthma—Progesterone—uterine cancer	0.000553	0.00545	CcSEcCtD
Prochlorperazine—Dysphagia—Progesterone—uterine cancer	0.000553	0.00545	CcSEcCtD
Prochlorperazine—Urinary retention—Medroxyprogesterone Acetate—uterine cancer	0.000552	0.00543	CcSEcCtD
Prochlorperazine—Apnoea—Etoposide—uterine cancer	0.000532	0.00524	CcSEcCtD
Prochlorperazine—Weight increased—Progesterone—uterine cancer	0.000503	0.00496	CcSEcCtD
Prochlorperazine—Dysphagia—Medroxyprogesterone Acetate—uterine cancer	0.000501	0.00494	CcSEcCtD
Prochlorperazine—Influenza—Medroxyprogesterone Acetate—uterine cancer	0.000501	0.00494	CcSEcCtD
Prochlorperazine—Asthma—Medroxyprogesterone Acetate—uterine cancer	0.000501	0.00494	CcSEcCtD
Prochlorperazine—Embolism venous—Epirubicin—uterine cancer	0.000501	0.00494	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Progesterone—uterine cancer	0.000499	0.00492	CcSEcCtD
Prochlorperazine—Drowsiness—Progesterone—uterine cancer	0.000493	0.00486	CcSEcCtD
Prochlorperazine—Jaundice—Progesterone—uterine cancer	0.000481	0.00474	CcSEcCtD
Prochlorperazine—Body temperature increased—Carboplatin—uterine cancer	0.000473	0.00467	CcSEcCtD
Prochlorperazine—Embolism venous—Doxorubicin—uterine cancer	0.000464	0.00457	CcSEcCtD
Prochlorperazine—Weight increased—Medroxyprogesterone Acetate—uterine cancer	0.000456	0.0045	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.000452	0.00446	CcSEcCtD
Prochlorperazine—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.000447	0.0044	CcSEcCtD
Prochlorperazine—Oedema peripheral—Progesterone—uterine cancer	0.000436	0.0043	CcSEcCtD
Prochlorperazine—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.000436	0.00429	CcSEcCtD
Prochlorperazine—Erythema multiforme—Progesterone—uterine cancer	0.000419	0.00413	CcSEcCtD
Prochlorperazine—Eruption—Epirubicin—uterine cancer	0.000411	0.00405	CcSEcCtD
Prochlorperazine—Oedema peripheral—Medroxyprogesterone Acetate—uterine cancer	0.000395	0.0039	CcSEcCtD
Prochlorperazine—Dysphagia—Dactinomycin—uterine cancer	0.000391	0.00385	CcSEcCtD
Prochlorperazine—Erythema—Progesterone—uterine cancer	0.000385	0.0038	CcSEcCtD
Prochlorperazine—Eruption—Doxorubicin—uterine cancer	0.00038	0.00375	CcSEcCtD
Prochlorperazine—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.000379	0.00374	CcSEcCtD
Prochlorperazine—Nervousness—Progesterone—uterine cancer	0.000374	0.00369	CcSEcCtD
Prochlorperazine—Pancytopenia—Dactinomycin—uterine cancer	0.000371	0.00366	CcSEcCtD
Prochlorperazine—Muscle spasms—Progesterone—uterine cancer	0.000371	0.00365	CcSEcCtD
Prochlorperazine—Vision blurred—Progesterone—uterine cancer	0.000363	0.00358	CcSEcCtD
Prochlorperazine—Tremor—Progesterone—uterine cancer	0.000361	0.00356	CcSEcCtD
Prochlorperazine—Angioedema—Progesterone—uterine cancer	0.000352	0.00347	CcSEcCtD
Prochlorperazine—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.000349	0.00344	CcSEcCtD
Prochlorperazine—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.000339	0.00334	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Etoposide—uterine cancer	0.000338	0.00333	CcSEcCtD
Prochlorperazine—Cough—Progesterone—uterine cancer	0.000336	0.00331	CcSEcCtD
Prochlorperazine—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.000336	0.00331	CcSEcCtD
Prochlorperazine—Convulsion—Progesterone—uterine cancer	0.000334	0.00329	CcSEcCtD
Prochlorperazine—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.000327	0.00322	CcSEcCtD
Prochlorperazine—Agranulocytosis—Dactinomycin—uterine cancer	0.000325	0.00321	CcSEcCtD
Prochlorperazine—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.000321	0.00316	CcSEcCtD
Prochlorperazine—Dry mouth—Progesterone—uterine cancer	0.000321	0.00316	CcSEcCtD
Prochlorperazine—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.000319	0.00315	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Progesterone—uterine cancer	0.000315	0.0031	CcSEcCtD
Prochlorperazine—Oedema—Progesterone—uterine cancer	0.000315	0.0031	CcSEcCtD
Prochlorperazine—Infection—Progesterone—uterine cancer	0.000313	0.00308	CcSEcCtD
Prochlorperazine—Glycosuria—Epirubicin—uterine cancer	0.000312	0.00308	CcSEcCtD
Prochlorperazine—Cardiac arrest—Etoposide—uterine cancer	0.000311	0.00307	CcSEcCtD
Prochlorperazine—Skin disorder—Progesterone—uterine cancer	0.000306	0.00301	CcSEcCtD
Prochlorperazine—Blood disorder—Epirubicin—uterine cancer	0.000303	0.00298	CcSEcCtD
Prochlorperazine—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.000303	0.00298	CcSEcCtD
Prochlorperazine—Liver injury—Epirubicin—uterine cancer	0.0003	0.00296	CcSEcCtD
Prochlorperazine—Erythema multiforme—Dactinomycin—uterine cancer	0.000296	0.00292	CcSEcCtD
Prochlorperazine—Hypotension—Progesterone—uterine cancer	0.000294	0.0029	CcSEcCtD
Prochlorperazine—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.000291	0.00287	CcSEcCtD
Prochlorperazine—Glycosuria—Doxorubicin—uterine cancer	0.000289	0.00285	CcSEcCtD
Prochlorperazine—Jaundice cholestatic—Epirubicin—uterine cancer	0.000288	0.00284	CcSEcCtD
Prochlorperazine—Amenorrhoea—Epirubicin—uterine cancer	0.000288	0.00284	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000285	0.00281	CcSEcCtD
Prochlorperazine—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.000285	0.00281	CcSEcCtD
Prochlorperazine—Insomnia—Progesterone—uterine cancer	0.000285	0.0028	CcSEcCtD
Prochlorperazine—Infection—Medroxyprogesterone Acetate—uterine cancer	0.000283	0.00279	CcSEcCtD
Prochlorperazine—Dysphagia—Etoposide—uterine cancer	0.000283	0.00279	CcSEcCtD
Prochlorperazine—Dyspnoea—Progesterone—uterine cancer	0.00028	0.00276	CcSEcCtD
Prochlorperazine—Blood disorder—Doxorubicin—uterine cancer	0.00028	0.00276	CcSEcCtD
Prochlorperazine—Somnolence—Progesterone—uterine cancer	0.00028	0.00276	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000279	0.00275	CcSEcCtD
Prochlorperazine—Liver injury—Doxorubicin—uterine cancer	0.000278	0.00274	CcSEcCtD
Prochlorperazine—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000277	0.00273	CcSEcCtD
Prochlorperazine—Erythema—Dactinomycin—uterine cancer	0.000272	0.00268	CcSEcCtD
Prochlorperazine—Dyskinesia—Epirubicin—uterine cancer	0.000269	0.00265	CcSEcCtD
Prochlorperazine—Constipation—Progesterone—uterine cancer	0.000269	0.00265	CcSEcCtD
Prochlorperazine—Pancytopenia—Etoposide—uterine cancer	0.000269	0.00265	CcSEcCtD
Prochlorperazine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000266	0.00262	CcSEcCtD
Prochlorperazine—Jaundice cholestatic—Doxorubicin—uterine cancer	0.000266	0.00262	CcSEcCtD
Prochlorperazine—Amenorrhoea—Doxorubicin—uterine cancer	0.000266	0.00262	CcSEcCtD
Prochlorperazine—Gait disturbance—Epirubicin—uterine cancer	0.000259	0.00255	CcSEcCtD
Prochlorperazine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000258	0.00254	CcSEcCtD
Prochlorperazine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000254	0.0025	CcSEcCtD
Prochlorperazine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000253	0.0025	CcSEcCtD
Prochlorperazine—Hepatocellular injury—Epirubicin—uterine cancer	0.000253	0.00249	CcSEcCtD
Prochlorperazine—Pulmonary embolism—Epirubicin—uterine cancer	0.000253	0.00249	CcSEcCtD
Prochlorperazine—Urticaria—Progesterone—uterine cancer	0.00025	0.00246	CcSEcCtD
Prochlorperazine—Dermatitis contact—Epirubicin—uterine cancer	0.00025	0.00246	CcSEcCtD
Prochlorperazine—Dyskinesia—Doxorubicin—uterine cancer	0.000249	0.00245	CcSEcCtD
Prochlorperazine—Body temperature increased—Progesterone—uterine cancer	0.000249	0.00245	CcSEcCtD
Prochlorperazine—Jaundice—Etoposide—uterine cancer	0.000246	0.00242	CcSEcCtD
Prochlorperazine—Leukopenia—Dactinomycin—uterine cancer	0.000244	0.0024	CcSEcCtD
Prochlorperazine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000244	0.0024	CcSEcCtD
Prochlorperazine—Gait disturbance—Doxorubicin—uterine cancer	0.00024	0.00236	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Epirubicin—uterine cancer	0.000237	0.00234	CcSEcCtD
Prochlorperazine—Agranulocytosis—Etoposide—uterine cancer	0.000235	0.00232	CcSEcCtD
Prochlorperazine—Hepatocellular injury—Doxorubicin—uterine cancer	0.000234	0.00231	CcSEcCtD
Prochlorperazine—Pulmonary embolism—Doxorubicin—uterine cancer	0.000234	0.00231	CcSEcCtD
Prochlorperazine—Hypersensitivity—Progesterone—uterine cancer	0.000232	0.00228	CcSEcCtD
Prochlorperazine—Dermatitis contact—Doxorubicin—uterine cancer	0.000231	0.00228	CcSEcCtD
Prochlorperazine—Coma—Epirubicin—uterine cancer	0.000231	0.00228	CcSEcCtD
Prochlorperazine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000226	0.00223	CcSEcCtD
Prochlorperazine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000225	0.00222	CcSEcCtD
Prochlorperazine—Pruritus—Progesterone—uterine cancer	0.000223	0.00219	CcSEcCtD
Prochlorperazine—Oedema—Dactinomycin—uterine cancer	0.000222	0.00219	CcSEcCtD
Prochlorperazine—Infection—Dactinomycin—uterine cancer	0.000221	0.00218	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Doxorubicin—uterine cancer	0.00022	0.00216	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Dactinomycin—uterine cancer	0.000218	0.00215	CcSEcCtD
Prochlorperazine—Erythema multiforme—Etoposide—uterine cancer	0.000214	0.00211	CcSEcCtD
Prochlorperazine—Coma—Doxorubicin—uterine cancer	0.000214	0.00211	CcSEcCtD
Prochlorperazine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00021	0.00207	CcSEcCtD
Prochlorperazine—Photosensitivity—Epirubicin—uterine cancer	0.000209	0.00206	CcSEcCtD
Prochlorperazine—Dizziness—Progesterone—uterine cancer	0.000208	0.00205	CcSEcCtD
Prochlorperazine—Eczema—Epirubicin—uterine cancer	0.000204	0.00201	CcSEcCtD
Prochlorperazine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000202	0.00199	CcSEcCtD
Prochlorperazine—Rash—Progesterone—uterine cancer	0.000198	0.00195	CcSEcCtD
Prochlorperazine—Dermatitis—Progesterone—uterine cancer	0.000198	0.00195	CcSEcCtD
Prochlorperazine—Headache—Progesterone—uterine cancer	0.000197	0.00194	CcSEcCtD
Prochlorperazine—Increased appetite—Epirubicin—uterine cancer	0.000195	0.00193	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Epirubicin—uterine cancer	0.000195	0.00192	CcSEcCtD
Prochlorperazine—Photosensitivity—Doxorubicin—uterine cancer	0.000193	0.00191	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Epirubicin—uterine cancer	0.00019	0.00187	CcSEcCtD
Prochlorperazine—Muscle spasms—Etoposide—uterine cancer	0.00019	0.00187	CcSEcCtD
Prochlorperazine—Eczema—Doxorubicin—uterine cancer	0.000189	0.00186	CcSEcCtD
Prochlorperazine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000189	0.00186	CcSEcCtD
Prochlorperazine—Hypoglycaemia—Epirubicin—uterine cancer	0.000188	0.00185	CcSEcCtD
Prochlorperazine—Increased appetite—Doxorubicin—uterine cancer	0.000181	0.00178	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.00018	0.00177	CcSEcCtD
Prochlorperazine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00018	0.00177	CcSEcCtD
Prochlorperazine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00018	0.00177	CcSEcCtD
Prochlorperazine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000179	0.00176	CcSEcCtD
Prochlorperazine—Leukopenia—Etoposide—uterine cancer	0.000177	0.00174	CcSEcCtD
Prochlorperazine—Body temperature increased—Dactinomycin—uterine cancer	0.000176	0.00173	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000175	0.00173	CcSEcCtD
Prochlorperazine—Cardiac arrest—Epirubicin—uterine cancer	0.000175	0.00172	CcSEcCtD
Prochlorperazine—Hypoglycaemia—Doxorubicin—uterine cancer	0.000174	0.00171	CcSEcCtD
Prochlorperazine—Cough—Etoposide—uterine cancer	0.000172	0.0017	CcSEcCtD
Prochlorperazine—Convulsion—Etoposide—uterine cancer	0.000171	0.00168	CcSEcCtD
Prochlorperazine—Hypersensitivity—Dactinomycin—uterine cancer	0.000164	0.00161	CcSEcCtD
Prochlorperazine—Cardiac arrest—Doxorubicin—uterine cancer	0.000161	0.00159	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Etoposide—uterine cancer	0.000161	0.00159	CcSEcCtD
Prochlorperazine—Infection—Etoposide—uterine cancer	0.00016	0.00158	CcSEcCtD
Prochlorperazine—Dysphagia—Epirubicin—uterine cancer	0.000159	0.00156	CcSEcCtD
Prochlorperazine—Asthma—Epirubicin—uterine cancer	0.000159	0.00156	CcSEcCtD
Prochlorperazine—Influenza—Epirubicin—uterine cancer	0.000159	0.00156	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Etoposide—uterine cancer	0.000158	0.00155	CcSEcCtD
Prochlorperazine—Eosinophilia—Epirubicin—uterine cancer	0.000157	0.00155	CcSEcCtD
Prochlorperazine—Skin disorder—Etoposide—uterine cancer	0.000156	0.00154	CcSEcCtD
Prochlorperazine—Pancytopenia—Epirubicin—uterine cancer	0.000151	0.00148	CcSEcCtD
Prochlorperazine—Hypotension—Etoposide—uterine cancer	0.00015	0.00148	CcSEcCtD
Prochlorperazine—Dysphagia—Doxorubicin—uterine cancer	0.000147	0.00145	CcSEcCtD
Prochlorperazine—Influenza—Doxorubicin—uterine cancer	0.000147	0.00145	CcSEcCtD
Prochlorperazine—Asthma—Doxorubicin—uterine cancer	0.000147	0.00145	CcSEcCtD
Prochlorperazine—Eosinophilia—Doxorubicin—uterine cancer	0.000145	0.00143	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Epirubicin—uterine cancer	0.000145	0.00143	CcSEcCtD
Prochlorperazine—Weight increased—Epirubicin—uterine cancer	0.000144	0.00142	CcSEcCtD
Prochlorperazine—Dyspnoea—Etoposide—uterine cancer	0.000143	0.00141	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Epirubicin—uterine cancer	0.000143	0.00141	CcSEcCtD
Prochlorperazine—Somnolence—Etoposide—uterine cancer	0.000143	0.00141	CcSEcCtD
Prochlorperazine—Drowsiness—Epirubicin—uterine cancer	0.000141	0.00139	CcSEcCtD
Prochlorperazine—Rash—Dactinomycin—uterine cancer	0.00014	0.00138	CcSEcCtD
Prochlorperazine—Pancytopenia—Doxorubicin—uterine cancer	0.000139	0.00137	CcSEcCtD
Prochlorperazine—Jaundice—Epirubicin—uterine cancer	0.000138	0.00136	CcSEcCtD
Prochlorperazine—Constipation—Etoposide—uterine cancer	0.000138	0.00136	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000134	0.00132	CcSEcCtD
Prochlorperazine—Weight increased—Doxorubicin—uterine cancer	0.000134	0.00132	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Doxorubicin—uterine cancer	0.000132	0.0013	CcSEcCtD
Prochlorperazine—Agranulocytosis—Epirubicin—uterine cancer	0.000132	0.0013	CcSEcCtD
Prochlorperazine—Drowsiness—Doxorubicin—uterine cancer	0.000131	0.00129	CcSEcCtD
Prochlorperazine—Urticaria—Etoposide—uterine cancer	0.000128	0.00126	CcSEcCtD
Prochlorperazine—Jaundice—Doxorubicin—uterine cancer	0.000128	0.00126	CcSEcCtD
Prochlorperazine—Body temperature increased—Etoposide—uterine cancer	0.000127	0.00125	CcSEcCtD
Prochlorperazine—Oedema peripheral—Epirubicin—uterine cancer	0.000125	0.00123	CcSEcCtD
Prochlorperazine—Agranulocytosis—Doxorubicin—uterine cancer	0.000122	0.0012	CcSEcCtD
Prochlorperazine—Erythema multiforme—Epirubicin—uterine cancer	0.00012	0.00118	CcSEcCtD
Prochlorperazine—Hypersensitivity—Etoposide—uterine cancer	0.000119	0.00117	CcSEcCtD
Prochlorperazine—Oedema peripheral—Doxorubicin—uterine cancer	0.000116	0.00114	CcSEcCtD
Prochlorperazine—Pruritus—Etoposide—uterine cancer	0.000114	0.00112	CcSEcCtD
Prochlorperazine—Arrhythmia—Epirubicin—uterine cancer	0.000113	0.00112	CcSEcCtD
Prochlorperazine—Erythema multiforme—Doxorubicin—uterine cancer	0.000111	0.00109	CcSEcCtD
Prochlorperazine—Erythema—Epirubicin—uterine cancer	0.000111	0.00109	CcSEcCtD
Prochlorperazine—Nervousness—Epirubicin—uterine cancer	0.000107	0.00106	CcSEcCtD
Prochlorperazine—Dizziness—Etoposide—uterine cancer	0.000106	0.00105	CcSEcCtD
Prochlorperazine—Muscle spasms—Epirubicin—uterine cancer	0.000106	0.00105	CcSEcCtD
Prochlorperazine—Arrhythmia—Doxorubicin—uterine cancer	0.000105	0.00103	CcSEcCtD
Prochlorperazine—Vision blurred—Epirubicin—uterine cancer	0.000104	0.00103	CcSEcCtD
Prochlorperazine—Erythema—Doxorubicin—uterine cancer	0.000102	0.00101	CcSEcCtD
Prochlorperazine—Agitation—Epirubicin—uterine cancer	0.000102	0.001	CcSEcCtD
Prochlorperazine—Rash—Etoposide—uterine cancer	0.000101	0.001	CcSEcCtD
Prochlorperazine—Dermatitis—Etoposide—uterine cancer	0.000101	0.000999	CcSEcCtD
Prochlorperazine—Headache—Etoposide—uterine cancer	0.000101	0.000993	CcSEcCtD
Prochlorperazine—Nervousness—Doxorubicin—uterine cancer	9.93e-05	0.000979	CcSEcCtD
Prochlorperazine—Leukopenia—Epirubicin—uterine cancer	9.89e-05	0.000975	CcSEcCtD
Prochlorperazine—Muscle spasms—Doxorubicin—uterine cancer	9.83e-05	0.000969	CcSEcCtD
Prochlorperazine—Cough—Epirubicin—uterine cancer	9.65e-05	0.00095	CcSEcCtD
Prochlorperazine—Vision blurred—Doxorubicin—uterine cancer	9.64e-05	0.00095	CcSEcCtD
Prochlorperazine—Convulsion—Epirubicin—uterine cancer	9.58e-05	0.000944	CcSEcCtD
Prochlorperazine—Agitation—Doxorubicin—uterine cancer	9.4e-05	0.000926	CcSEcCtD
Prochlorperazine—Dry mouth—Epirubicin—uterine cancer	9.2e-05	0.000907	CcSEcCtD
Prochlorperazine—Leukopenia—Doxorubicin—uterine cancer	9.15e-05	0.000902	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Epirubicin—uterine cancer	9.02e-05	0.000889	CcSEcCtD
Prochlorperazine—Oedema—Epirubicin—uterine cancer	9.02e-05	0.000889	CcSEcCtD
Prochlorperazine—Infection—Epirubicin—uterine cancer	8.96e-05	0.000883	CcSEcCtD
Prochlorperazine—Cough—Doxorubicin—uterine cancer	8.92e-05	0.000879	CcSEcCtD
Prochlorperazine—Convulsion—Doxorubicin—uterine cancer	8.86e-05	0.000873	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Epirubicin—uterine cancer	8.83e-05	0.00087	CcSEcCtD
Prochlorperazine—Skin disorder—Epirubicin—uterine cancer	8.76e-05	0.000863	CcSEcCtD
Prochlorperazine—Dry mouth—Doxorubicin—uterine cancer	8.52e-05	0.000839	CcSEcCtD
Prochlorperazine—Hypotension—Epirubicin—uterine cancer	8.43e-05	0.000831	CcSEcCtD
Prochlorperazine—Oedema—Doxorubicin—uterine cancer	8.35e-05	0.000823	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Doxorubicin—uterine cancer	8.35e-05	0.000823	CcSEcCtD
Prochlorperazine—Infection—Doxorubicin—uterine cancer	8.29e-05	0.000817	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Doxorubicin—uterine cancer	8.17e-05	0.000805	CcSEcCtD
Prochlorperazine—Insomnia—Epirubicin—uterine cancer	8.16e-05	0.000804	CcSEcCtD
Prochlorperazine—Skin disorder—Doxorubicin—uterine cancer	8.11e-05	0.000799	CcSEcCtD
Prochlorperazine—Dyspnoea—Epirubicin—uterine cancer	8.04e-05	0.000793	CcSEcCtD
Prochlorperazine—Somnolence—Epirubicin—uterine cancer	8.02e-05	0.00079	CcSEcCtD
Prochlorperazine—Hypotension—Doxorubicin—uterine cancer	7.8e-05	0.000769	CcSEcCtD
Prochlorperazine—Constipation—Epirubicin—uterine cancer	7.71e-05	0.00076	CcSEcCtD
Prochlorperazine—Insomnia—Doxorubicin—uterine cancer	7.55e-05	0.000744	CcSEcCtD
Prochlorperazine—Dyspnoea—Doxorubicin—uterine cancer	7.44e-05	0.000733	CcSEcCtD
Prochlorperazine—Somnolence—Doxorubicin—uterine cancer	7.42e-05	0.000731	CcSEcCtD
Prochlorperazine—Urticaria—Epirubicin—uterine cancer	7.17e-05	0.000706	CcSEcCtD
Prochlorperazine—Constipation—Doxorubicin—uterine cancer	7.14e-05	0.000703	CcSEcCtD
Prochlorperazine—Body temperature increased—Epirubicin—uterine cancer	7.13e-05	0.000703	CcSEcCtD
Prochlorperazine—Hypersensitivity—Epirubicin—uterine cancer	6.65e-05	0.000655	CcSEcCtD
Prochlorperazine—Urticaria—Doxorubicin—uterine cancer	6.63e-05	0.000653	CcSEcCtD
Prochlorperazine—Body temperature increased—Doxorubicin—uterine cancer	6.6e-05	0.00065	CcSEcCtD
Prochlorperazine—Pruritus—Epirubicin—uterine cancer	6.38e-05	0.000629	CcSEcCtD
Prochlorperazine—Hypersensitivity—Doxorubicin—uterine cancer	6.15e-05	0.000606	CcSEcCtD
Prochlorperazine—Dizziness—Epirubicin—uterine cancer	5.97e-05	0.000588	CcSEcCtD
Prochlorperazine—Pruritus—Doxorubicin—uterine cancer	5.91e-05	0.000582	CcSEcCtD
Prochlorperazine—Rash—Epirubicin—uterine cancer	5.69e-05	0.00056	CcSEcCtD
Prochlorperazine—Dermatitis—Epirubicin—uterine cancer	5.68e-05	0.00056	CcSEcCtD
Prochlorperazine—Headache—Epirubicin—uterine cancer	5.65e-05	0.000557	CcSEcCtD
Prochlorperazine—Dizziness—Doxorubicin—uterine cancer	5.52e-05	0.000544	CcSEcCtD
Prochlorperazine—Rash—Doxorubicin—uterine cancer	5.26e-05	0.000519	CcSEcCtD
Prochlorperazine—Dermatitis—Doxorubicin—uterine cancer	5.26e-05	0.000518	CcSEcCtD
Prochlorperazine—Headache—Doxorubicin—uterine cancer	5.23e-05	0.000515	CcSEcCtD
